JORVIK GILLYGATE PRACTICE
WOOLPACK HOUSE, THE STONEBOW, YORK
HF003
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, the percentage of patients who are currently treated with an ACE-I or ARB
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| LVD 3 | 2005 | 51 | 57 | 89.5% | |
| LVD 3 | 2006 | 44 | 53 | 83.0% | |
| HF 3 | 2007 | 38 | 44 | 86.4% | |
| HF 3 | 2008 | 38 | 46 | 82.6% | |
| HF 3 | 2009 | 51 | 59 | 86.4% | |
| HF 3 | 2010 | 50 | 54 | 92.6% | |
| HF 3 | 2011 | 52 | 57 | 91.2% | |
| HF 3 | 2012 | 50 | 59 | 84.7% | |
| HF 3 | 2013 | 50 | 61 | 82.0% | |
| HF003 | 2014 | 8 | 8 | 100.0% | |
| HF003 | 2015 | 13 | 13 | 100.0% | |
| HF003 | 2016 | 18 | 18 | 100.0% | |
| HF003 | 2017 | 29 | 29 | 100.0% | |
| HF003 | 2018 | 67 | 67 | 100.0% | |
| HF003 | 2019 | 64 | 64 | 100.0% | |
| HF003 | 2020 | 60 | 60 | 100.0% | |
| HF003 | 2021 | 74 | 85 | 87.1% | |
| HF003 | 2022 | 144 | 152 | 94.7% | |
| HF003 | 2023 | 136 | 146 | 93.2% |
